PREdicts personal diabetes risk and drives long-term behavioral change
Sweetch has raised €6.2M across 3 funding rounds from 5 investors, most recently a Series A round in Dec 2018. Based in Tel Aviv, Israel; founded 2013; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2018-12-12 | Series A | €3.1M | OurCrowd | View deal → |
| 2016-04-01 | Series A | €3.1M | LionBird,Philips,Pontifax Funds | View deal → |
| 2015-04-01 | Seed | €0 | SEEDIL | View deal → |
